Epigenetic cancer therapies: DNA methyltransferase inhibitors
- 1 June 2002
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 11 (6), 747-754
- https://doi.org/10.1517/13543784.11.6.747
Abstract
Human cancers frequently show altered patterns of DNA methylation, particularly at CpG islands. These CpG islands are sequences of DNA rich in CpG dinucleotides and are often found close to gene promoters. Methylation within islands has been shown to be associated with transcriptional repression of the linked gene. Genes involved in all facets of tumour development and progression can become methylated and epigenetically silenced. Re-expression of such silenced genes can lead to suppression of tumour growth or sensitisation to anticancer therapies. Agents that can reverse DNA methylation include nucleoside and non-nucleoside inhibitors of DNA methyltransferase. Such agents are now undergoing preclinical evaluation and clinical trials in cancer patients.Keywords
This publication has 35 references indexed in Scilit:
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Methylation mattersJournal of Medical Genetics, 2001
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- Increased DNA methyltransferase expression in leukaemiaLeukemia, 1998
- Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation.Proceedings of the National Academy of Sciences, 1996
- Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer.Proceedings of the National Academy of Sciences, 1996
- Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instabilityNature Genetics, 1995
- Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancerNature, 1994
- Increased Cytosine DNA-Methyltransferase Activity During Colon Cancer ProgressionJNCI Journal of the National Cancer Institute, 1993
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992